[en] The use of high levels of cryoprotectants (CPs) in solutions applied to vitrify oocytes or embryos is an argument to still prefer slow freezing procedure. Is it a justified argument? Out of three studies using mice zygotes we may assume that (i) the intracellular concentration of CPs is far lower than the one in the vitrification solutions, (ii) the intracellular concentration of CPs in the vitrified zygote is in contrary to the common beliefs even lower than the one observed after a slow freezing procedure, (iii) survival after slow freezing reflects the presence of an intracellular vitrified state in these cells.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
M. Wikland, T. Hardarson, T. Hillensjö, C. Westin, G. Westlander, and M. Wood Obstetric outcomes after transfer of vitrified blastocysts Hum Reprod 25 2010 1699 1707
R. Chian, J. Huang, and S. Tan Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes RBM online 16 2008 608 610
P. Vanderzwalmen, F. Ectors, L. Grobet, Y. Prapas, Y. Panagiotidis, and S. Vanderzwalmen Development of an aseptic vitrification technique: application to blastocysts originating from infertile patients, egg donors and after in vitro maturation RBM online 19 2009 700 707
S. Yavin, and A. Arav Measurement of essential physical properties of vitrification solutions Theriogenology 67 2007 81 89
P. Vanderzwalmen, G. Bertin, and Debauche Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing Hum Reprod 18 2003 1504 1511
A. Vansteenbrugge, P. Vanderzwalmen, C. Vastersaegher, and P. Pauwels Does high concentration of cryoprotectant during vitrification of blastocysts present any risks? Hum Reprod 22 2007 P387
P. Mazur Kinetics of water loss from cells at subzero temperatures and the likelihood of intracellular freezing J Gen Physiol 47 1963 347 369
